Who makes LIM-0705 and tacrolimus?

LIM-0705 and tacrolimus is developed by Limerick BioPharma.

What development phase is LIM-0705 and tacrolimus in?

LIM-0705 and tacrolimus is in Phase 1.

Last reviewed 2026-04-19 · How we verify

LIM-0705 and tacrolimus

Limerick BioPharma · Phase 1 active Small molecule

At a glance

Generic name	LIM-0705 and tacrolimus
Sponsor	Limerick BioPharma
Modality	Small molecule
Phase	Phase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Safety and Tolerability of LIM-0705 in Healthy Male Subjects (PHASE1)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

LIM-0705 and tacrolimus CI brief — competitive landscape report
LIM-0705 and tacrolimus updates RSS · CI watch RSS
Limerick BioPharma portfolio CI